Genmab Logo

Genmab

🇩🇰
GMAB
DK0010272202

Genmab is an international Danish biotechnology company focused on the research, development, and commercialization of innovative antibody therapeutics. The company is dedicated to improving the quality of life for patients with cancer and other serious diseases by bringing groundbreaking medicines to market.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Genmab report its next quarterly earnings?

Genmab is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Genmab last report quarterly earnings?

Genmab last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 32.21 DKK.

How does Genmab stock react to earnings?

Across its last 4 earnings reports, Genmab stock moved by ±1.7% on average the following day. The largest reaction was +4.4% on 02/17/2026; 3 of 4 reactions were positive.

How often has Genmab beaten expectations?

Genmab has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Genmab earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:DKK 23.84
Actual:
Q2 2026
Beat
Estimate:DKK 23.36
Actual:DKK 32.21
Difference:+DKK 8.85
Q1 2026
Missed
Estimate:DKK 10.12
Actual:DKK 5.39
Difference:-DKK 4.73
Price reaction (1 day):-0.6 %
Price reaction (7 days):-4.5 %
Q4 2025
Missed
Estimate:DKK 27.36
Actual:DKK 3.18
Difference:-DKK 24.18
Price reaction (1 day):+4.4 %
Price reaction (7 days):-1.0 %
Q3 2025
Beat
Estimate:$31.81
Actual:$41.80
Difference:+$9.99
Price reaction (1 day):+1.6 %
Price reaction (7 days):+6.8 %
Q1 2025
Beat
Estimate:$25.72
Actual:$34.77
Difference:+$9.05
Q4 2024
Estimate:
Actual:
Price reaction (1 day):0.0 %
Price reaction (7 days):+12.9 %

Earnings statistics

Stock reaction to earnings

±1.7%
Avg. next-day move
+4.4%
Largest move (02/17/2026)
75%
Share of positive reactions
±6.3%
Avg. move after 7 days

Basis: price reactions to the last 4 report dates (close to close).

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-19.3%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Genmab
Ticker Symbol
GMAB
ISIN
DK0010272202
Country
🇩🇰
Denmark
Sector
More Financial Information